Covered recipient · General Payments record
SHILPA MANOHAR JOGLEKAR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,895.18
- Reported across 166 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.42 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $164.31 | 8 |
| PFIZER INC. | $133.59 | 12 |
| Acerta Pharma LLC | $58.44 | 3 |
| Sumitomo Pharma America, Inc. | $36.99 | 2 |
| Exact Sciences Corporation | $20.52 | 1 |
| Amgen Inc. | $17.30 | 1 |
| ABBVIE INC. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.27 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998835 | CMS |
| Amgen Inc. | $17.30 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117589409 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105202332 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.73 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104581958 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.83 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105474681 | CMS |
| Exact Sciences Corporation | $20.52 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114720106 | CMS |
| Novo Nordisk Inc | $19.09 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096831632 | CMS |
| Novo Nordisk Inc | $22.50 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097378151 | CMS |
| Novo Nordisk Inc | $15.90 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097168167 | CMS |
| Novo Nordisk Inc | $21.36 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097635879 | CMS |
| Novo Nordisk Inc | $19.79 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096960698 | CMS |
| Novo Nordisk Inc | $15.63 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096805540 | CMS |
| Novo Nordisk Inc | $28.25 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674829 | CMS |
| Novo Nordisk Inc | $21.79 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097658821 | CMS |
| PFIZER INC. | $20.78 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131170044 | CMS |
| PFIZER INC. | $4.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130896218 | CMS |
| PFIZER INC. | $3.36 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130904374 | CMS |
| PFIZER INC. | $26.08 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131390317 | CMS |
| PFIZER INC. | $9.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130908903 | CMS |
| PFIZER INC. | $4.72 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130913190 | CMS |
| PFIZER INC. | $3.34 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130934781 | CMS |
| PFIZER INC. | $3.80 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130939368 | CMS |
| PFIZER INC. | $28.85 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131843692 | CMS |
| PFIZER INC. | $20.39 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131972809 | CMS |
| PFIZER INC. | $4.49 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130978113 | CMS |
| PFIZER INC. | $3.71 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131210402 | CMS |
| Sumitomo Pharma America, Inc. | $18.97 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148869767 | CMS |
| Sumitomo Pharma America, Inc. | $18.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148869769 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.